On the occasion of the #InternationalWomensDay @pd-perls.bsky.social and I chat with three extraordinary women in #peritonealdialysis on a new special episode of the #PDExchange #podcast Podcast Link Spotify - spoti.fi/3DxBOli Apple - apple.co/3pboqwa @ispd.org @pdi-journal.bsky.social

Excited to participate in the upcoming PD Meeting in Kiel which is the 1st International Meeting on Cellular and Molecular Peritoneal Dialysis Research! Join us to explore cutting-edge research, network with experts, and advance peritoneal dialysis care. pdmeeting.skip-sh.de

Giedre’s excellent thesis is now available for download at Lund University: portal.research.lu.se/en/publicati... Brings tears to the eyes of a true Peritoneal Dialysis Nerd 🎓🎓🎓

#NephJC One of the slides from @bhallaresearch.bsky.social at #ISNWCN Primary aldosteronism is an elephant in the room, encountered at all stages of HTN, and even with normotension. Brown, et al, 2020

Some good news - a vaccine to prevent kidney cancer returning. It’s a small sample at this stage, but there were zero cases of recurrence.

Clazakizumab, an IL-6 inhibitor, improves iron metabolism & may reduce ESA use in dialysis ✅ ↓ Hepcidin (~44%) ✅ ↑ TSAT (up to 19%) ✅ ↓ ESA dose uptitration P3 trial (n=2,200) ongoing for CV outcomes. Our findings now in JASN @asnpublications.bsky.social : journals.lww.com/jasn/citatio...

1/ 📢 New research alert: The creatinine-cystatin C (Cr/CysC) ratio is shown to predict mortality and technique failure in anuric peritoneal dialysis (PD) patients. This marker might improve patient risk stratification. #RenalFailure #DialysisCare #ClinicalResearch

Open-label, Randomized, Controlled, Crossover Trial on the Effect of #Dapagliflozin in Patients with Autosomal Dominant Polycystic Kidney Disease #ADPKD Receiving #Tolvaptan #VisualAbstract by @md_abdulqader83 www.kireports.org/ar...

💡 "Can you survive by drinking water from the Baltic Sea?" 🌊💧 A student asked me an interesting question: You can’t survive on seawater (~35 g/L salt), but the Baltic Sea surrounding Sweden only has 7 g/L. Could that be low enough for survival? Let’s dive in. 🧵✨

Our recent study shows that glucose can cross peritoneal cells via a trans-cellular route during peritoneal dialysis, with evidence pointing to GLUT1 as playing a key role. This thread 🧵outlines the design and findings of the study. doi.org/10.1177/0896...

@pdi-journal.bsky.social @ispd.org @pd-perls.bsky.social Original Article - journals.sagepub.com/doi/full/10.... Editorial - @johannmorelle.bsky.social @carloberg.bsky.social journals.sagepub.com/doi/full/10.... VA - @jmteakell.bsky.social

Can we trust eGFR results? The answer of IA ! bmcnephrol.biomedcentral.com/articles/10.... trustekfcegfr.shinyapps.io/GFR_shiny_La... Thanks to the EKFC! Thanks to Antoine Lanot

🎓📢📢 My PhD student Giedre Martus will publicly defend her doctoral thesis: "Clinical, Experimental and Theoretical Studies of Solute and Water Removal in Peritoneal Dialysis" 📅 March 6, 2025, at 1:00 PM CET 📍 Alwall House, SUS Lund (and via Zoom: lu-se.zoom.us/j/61103791502)

Will Xylocore® be the magic ELIXIR for peritoneal dialysis? @ispd.org @pdi-journal.bsky.social @drnikhilshah.bsky.social @pd-perls.bsky.social @mlambie.bsky.social Editorial: journals.sagepub.com/eprint/ENYAN... Original article: journals.sagepub.com/doi/10.1177/...

🚨 New Research Alert! 🚨 Can phloretin (from apple trees 🍏) enhance peritoneal dialysis? Our study shows potent effects on: ✅ Improving ultrafiltration ✅ Reducing glucose absorption via GLUT inhibition ✅ Clear dose-response relationship in experimental models bit.ly/KID0717